Stock DIAGNOSTIC MEDICAL
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases DIAGNOSTIC MEDICAL Euronext Paris

Equities

FR0000063224

End-of-day quote Euronext Paris
Other stock markets
- EUR - Intraday chart for DIAGNOSTIC MEDICAL
May. 15 Qiagen's Updated Clinical Decision Support Platform Secures EU Certification MT
Apr. 18 Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Diagnostic Medical : 11/06/2024 – DMS Group Announces Strategic Agreement with Medlink Imaging for the Sale of M1 Radiology Solutions in the United States
PU
Diagnostic Medical : Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024
PU
Diagnostic Medical Systems : DMS GROUP : Finalisation of the acquisition of Solutions For Tomorrow (SFT). DMS Group expands into mobile medical imaging.
AT
Diagnostic Medical Systems : DMS GROUP : Agreement to acquire Solutions For Tomorrow (SFT). DMS Group expands into mobile medical imaging.
AT
Diagnostic Medical Systems : DMS GROUP : End of ongoing procedure with Thierry Legon and reinstatement of the judicial reorganization plan homologated on February 9, 2021.
AT
Diagnostic Medical Systems : Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives
AT
Diagnostic Medical Systems : 2022 revenue: EUR 35.8 m - 2023 targets and perspectives
AT
Diagnostic Medical Systems : Fujifilm Healthcare Italy wins tender for 96 X-ray tables, designed and produced by DMS Imaging, the imaging division of DMS Group
AT
Diagnostic Medical Systems : DMS Group reveals its new ambitions and presents its strategic plan: "Imaging 2027": becoming a key player of medical imaging in Europe
AT
Diagnostic Medical : 21/10/2022 – Signature of a memorandum of understanding to organize the sale of the block of shares held by DMS Group in Hybrigenics
PU
Diagnostic Medical Systems : 2022 bi-annual results: 4.6% of EBITDA margin Including 10.3% for the DMS Imaging division - Presentation of the future strategic plan in October 2022
AT
Diagnostic Medical Systems : Message of DMS Group’s Chief Executive Officer
AT
Dms (diagnostic Medical Systems) : Further progress for the DMS Biotech division: finalization of a pre-clinical study on the treatment of erectile dysfunctions
AT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALDMS Stock
  4. Stock
  5. News DIAGNOSTIC MEDICAL
  6. Press Releases